期刊文献+

丙戊酸钠对人肝癌SMMC-7221细胞的放疗增敏作用研究

Radiosensitization Effect of Valproic Acid on Human Hepatocellular Cell Line SMMC- 7221
原文传递
导出
摘要 目的探讨丙戊酸钠(VPA)对肝癌SMMC-7221细胞的放疗增敏作用及其机制探究。方法 MTT法检测VPA对肝癌SMMC-7221细胞的抑制率,筛选出VPA的半数抑制浓度(IC50)。流式细胞仪(FCM)分析肝癌SMMC-7221细胞周期及细胞凋亡率。结果 MTT结果显示VPA作用SMMC-7221细胞24、48、72 h后IC50分别为41.26、9.04、2.87 mmol/L。FCM结果显示VPA+IR抑制SMMC-7221细胞的增殖,增加凋亡水平和诱导G0/G1期阻滞。结论VPA作为放疗增敏剂,增加了SMMC-7221细胞的杀伤作用,其机制与细胞凋亡和细胞周期阻滞相关。 Objective To investigate radiosensitization effect of valproic acid (VPA) on human hepatocellular cell line SMMC -7221 and its mechanism. Methods MTY was used to detect the proliferation and IC50 of SMMC -7221 cell. FCM was adopted to analyze the changes in cell cycle and apoptosis level. Results After co - cultured with VPA , the IC50 of SMMC -7221 cell was 41.26,9.04,2.87mmol/L. VPA + IR could significantly inhibit the cell proliferation, increase apopto- sis level, cause G0/G1 phase arrest and decrease the decreased the percentages of S phrase. Conclusion VPA could enhance the cell -killing effect of SMMC -7221 cell as a radio - sensitizer, which was associated with apoptosis and cell cycle arrest
出处 《中国辐射卫生》 2014年第1期60-63,共4页 Chinese Journal of Radiological Health
关键词 肝癌 丙戊酸钠 放疗增敏 细胞凋亡 细胞周期 Hepatocellular Cancer Valproic Acid Radiosensitizer Apoptosis Cell Cycle
  • 相关文献

参考文献1

二级参考文献108

  • 1Paolo Piacentini,Massimo Donadelli,Chiara Costanzo,Patrick S. Moore,Marta Palmieri,Aldo Scarpa.Trichostatin A enhances the response of chemotherapeutic agents in inhibiting pancreatic cancer cell proliferation[J]. Virchows Archiv . 2006 (6)
  • 2Emilio Marengo,Elisa Robotti,Daniela Cecconi,Mahmoud Hamdan,Aldo Scarpa,Pier Giorgio Righetti.Identification of the regulatory proteins in human pancreatic cancers treated with Trichostatin A by 2D-PAGE maps and multivariate statistical analysis[J]. Analytical and Bioanalytical Chemistry . 2004 (7-8)
  • 3Barbara Miszczuk-Jamska,Marc Merten,Wanda Renaud,Odette Guy-Crotte,Catherine Figarella.Trypsinogen expression by two human pancreatic cell lines CFPAC-1 and CAPAN-1[J]. International Journal of Pancreatology . 1994 (1)
  • 4N. Bensaadi,F. Clemente,N. Vaysse.Modulation of enzymatic activities during spontaneous and induced differentiation in a human pancreatic adenocarcinoma cell line CAPAN-1[J]. International Journal of Pancreatology . 1989 (4)
  • 5L.S. Kristensen,H.M. Nielsen,L.L. Hansen.Epigenetics and cancer treatment. European Journal of Pharmacology . 2009
  • 6Rocha-Lima CM.New directions in the management of advanced pancreatic cancer:a review. Anti Cancer Drugs . 2008
  • 7Ries L,Eisner M,Kosary C,et al.SEER cancer statistics review, 1975-2000. . 2003
  • 8Rocha Lima CM,Green MR,Rotche R,et al.Irinotecan plus gemcitabine results in no survival advantage compared with gemcitabine monotherapy in patients with locally advanced or metastatic pancreatic cancer despite increased tumor response rate. Journal of Clinical Oncology . 2004
  • 9Cecconi D,Scarpa A,Donadelli M,et al.Proteomic profiling of pancreatic ductal carcinoma cell lines treated with trichostatin-A. Electrophoresis . 2003
  • 10Ohike N,Maass N,Mundhenke C,et al.Clinicopathological significance and molecular regulation of maspin expression in ductal adenocarcinoma of the pancreas. Cancer Letters . 2003

共引文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部